Search Results

UCLA scientist Dr. Aparna Bhaduri receives the 2026 Pershing Square Sohn Cancer Prize for pioneering organoid models aimed at improving glioblastoma treatment and immunotherapy research.

Researchers used a microfluidic device to capture biomarkers that are released by tumor cells to predict patient responses to chemotherapy drugs

Researchers shed new light on the cellular complexity of glioblastoma, the most aggressive type of brain cancer.

Glioblastoma is the most lethal type of primary brain cancer due to its aggressive nature and its treatment-resistant characteristics

Researchers from ETH Zurich discover that an approved antidepressant may help combat aggressive brain tumors, offering potential for future treatment

Glioblastoma (GB), disease that confounded oncologists for decades due to its aggressive nature and strong resistance to existing therapies.